Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Silo Pharma Inc
(NQ:
SILO
)
1.200
-0.030 (-2.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
78,037
Open
1.250
Bid (Size)
1.200 (25)
Ask (Size)
1.290 (3)
Prev. Close
1.230
Today's Range
1.190 - 1.260
52wk Range
0.8410 - 4.500
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO), Sever Pharma Expand Existing Agreement to Include Extrusion of Novel Ketamine Implant Therapeutic
August 15, 2024
Via
Investor Brand Network
Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic
August 14, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Performance
YTD
-21.05%
-21.05%
1 Month
-51.42%
-51.42%
3 Month
-37.50%
-37.50%
6 Month
-25.93%
-25.93%
1 Year
-39.09%
-39.09%
More News
Read More
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters Agreement to Launch New Study of SPU-16 Homing Peptide for Multiple Sclerosis
August 07, 2024
Via
Investor Brand Network
Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide
August 07, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Why Is Silo Pharma (SILO) Stock Up 60% Today?
July 18, 2024
Via
InvestorPlace
BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) to Participate in Upcoming H.C. Wainwright Annual Global Investment Conference
July 26, 2024
Via
Investor Brand Network
Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference
July 26, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
July 22, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Crude Oil Down 3%; Netflix Earnings Top Estimates
July 19, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why Selective Insurance Group Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 19, 2024
Via
Benzinga
BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Enters into $2.1M Registered Direct Offering
July 19, 2024
Via
Investor Brand Network
Gold Down 2%; SLB Posts Upbeat Earnings
July 19, 2024
Via
Benzinga
Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
July 19, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Nasdaq Down Over 100 Points; Abbott Laboratories Earnings Beat Views
July 18, 2024
Via
Benzinga
Topics
Earnings
Exposures
Financial
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 18, 2024
Via
Benzinga
Silo Pharma Finds Partner For Device Development for Intranasal PTSD Drug
July 18, 2024
Via
Benzinga
Dow Dips 250 Points; US Weekly Jobless Claims Surge
July 18, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Enters Device and CMC Development Master Plan to Support IND-Enabling Study of SPC-15
July 18, 2024
Via
Investor Brand Network
US Stocks Edge Higher; D.R. Horton Posts Upbeat Earnings
July 18, 2024
Via
Benzinga
Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15
July 18, 2024
From
Silo Pharma, Inc.
Via
GlobeNewswire
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
July 17, 2024
Via
Benzinga
Nasdaq Edges Lower; Morgan Stanley Earnings Top Views
July 16, 2024
Via
Benzinga
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 16, 2024
Via
Benzinga
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
July 16, 2024
Via
Benzinga
Exposures
Fossil Fuels
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Exclusive Global License to Develop, Manufacture, Commercialize Alzheimer Drug
July 16, 2024
Via
Investor Brand Network
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.